Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Denali Therapeutics Inc
(NQ:
DNLI
)
26.85
+0.02 (+0.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Denali Therapeutics Inc
< Previous
1
2
3
4
Next >
26 Stocks Moving In Thursday's Mid-Day Session
January 13, 2022
Gainers Dave Inc. (NASDAQ: DAVE) gained 29.4% to $6.73. Takung Art Co., Ltd. (NASDAQ: TKAT) shares gained 18.6% to $4.1499. Traders are circulating earlier news that China is...
Via
Benzinga
Mid-Morning Market Update: Markets Rise; Delta Air Lines Profit Tops Estimates
January 13, 2022
Following the market opening Thursday, the Dow traded up 0.37% to 36,423.44 while the NASDAQ rose 0.12% to 15,206.73. The S&P also rose, gaining, 0.21% to 4,736.11. The U.S....
Via
Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
The FDA has issued a clinical hold on Denali Therapeutics Inc's (NASDAQ: DNLI) Investigational New Drug (IND) application for DNL919 (ATV:TREM2). TREM2 is...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...
Via
Benzinga
Jim Cramer Says This Stock Is 'Really Cheap'
December 16, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Academy Sports and Outdoors (NYSE:
Via
Benzinga
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
November 23, 2021
Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market....
Via
FinancialNewsMedia
Exposures
COVID-19
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
October 07, 2021
Denali Therapeutics Inc (NASDAQ: DNLI) announced data from the Phase 1 trial evaluating DNL343, eIF2B activator, in 95 healthy volunteers. DNL343 was generally...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2021
September 21, 2021
Upgrades According to Compass Point, the prior rating for TriplePoint Venture Growth BDC Corp (NYSE:
Via
Benzinga
President And CEO Of Denali Therapeutics Sold $1.00 Million In Stock
September 03, 2021
Ryan Watts, President and CEO at Denali Therapeutics (NASDAQ:DNLI), made a large insider sell on September 1, according to a new SEC filing. What Happened: A Form 4 filing...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
74 Biggest Movers From Yesterday
July 27, 2021
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with...
Via
Benzinga
Why Denali Therapeutics Stock Is Sinking Today
July 26, 2021
The company reported interim results from a phase 1/2 study of its experimental Hunter syndrome drug.
Via
The Motley Fool
48 Stocks Moving In Monday's Mid-Day Session
July 26, 2021
Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The...
Via
Benzinga
Denali Therapeutics Stock Crashes; Why Investors Are Questioning Its Entire Pipeline
July 26, 2021
Denali unveiled promising test results in Hunter syndrome, but DNLI stock tanked Monday on broader pipeline viability questions.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 26, 2021
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million....
Via
Benzinga
Denali's Brain-Penetrant Enzyme Therapy Shows Durable Effect With CNS Impact In Hunter Syndrome
July 26, 2021
Denali Therapeutics Inc (NASDAQ: DNLI) announced additional interim data from a Phase 1/2 study evaluating ETV:IDS (DNL310) for the central nervous system (CNS)...
Via
Benzinga
Tuesday Talk: Action!
June 15, 2021
U.S. stock markets started the week in continued action mode. The S&P 500 closed at 4,255, up nearly 8 points, the Dow closed at 34,394, down 85 points and the Nasdaq Composite closed at 14,174, up...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Biotechs Ready To Roar
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...
Via
Benzinga
Biden's Budget May Boost These 3 Biotechs
May 10, 2021
It signals a big push toward curing a neurological disease with a massive market.
Via
The Motley Fool
Exposures
COVID-19
Denali-Biogen Parkinson's Disease Candidate Shows Reductions In Biomarkers; Late Study To Begin By 2021 End
May 03, 2021
Denali Therapeutics Inc (NASDAQ: DNLI) has announced final results from Phase 1 and Phase 1b studies evaluating BIIB122/DNL151 Parkinson's disease. The...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.